IVAX VERAPAMIL ER SALES ARE $145.9 MIL. IN 1993, OR 29% OF PHARMACEUTICAL NET REVENUES OF $500.5 MIL.; VALUE HEALTH 12-MONTH Rx DRUG REVENUES ARE $364.7 MIL.